부산대학교 도서관

Kugadas A; Rare Diseases Drug Discovery Unit, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.; Oncology and Immunology Unit, WuXi AppTec, Natick, Massachusetts, United States of America.; Artoni P; Statistical and Quantitative Sciences, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.; Ruangsiriluk W; Rare Diseases Drug Discovery Unit, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.; Crosswalk Therapeutics, Cambridge, Massachusetts, United States of America.; Zhao M; Statistical and Quantitative Sciences, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.; Boukharov N; Rare Diseases Drug Discovery Unit, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.; Crosswalk Therapeutics, Cambridge, Massachusetts, United States of America.; Islam R; Rare Diseases Drug Discovery Unit, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.; Crosswalk Therapeutics, Cambridge, Massachusetts, United States of America.; Volfson D; Statistical and Quantitative Sciences, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.; Derakhchan K; Rare Diseases Drug Discovery Unit, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.; Pioneering Medicines at Flagship Pioneering, Cambridge, Massachusetts, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Chen N; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Ehmann DE; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Pretzel Therapeutics, Waltham, MA, USA.; Crooker R; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Derakhchan K; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Fang X; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Asklepios BioPharmaceutical (AskBio), Research Triangle Park, NC, USA.; Felice B; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Galbreath EJ; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Glaus C; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Bayer HealthCare Pharmaceuticals, Cambridge, MA, USA.; Gu H; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; PTM Bio LLC, Hangzhou, Zhejiang, China.; Huang Y; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Editas Medicine, Cambridge, MA, USA.; Li C; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Li X; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Ultragenyx, Cambridge, MA, USA.; Liu N; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Palmieri K; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Simic D; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Astellas Gene Therapies, San Francisco, CA, USA.; Sypek J; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Thompson S; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Winkelmann CT; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Choi VW; Takeda Development Center Americas, Inc., Cambridge, MA, USA.

Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE

Tack J; Division of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Derakhchan K; Takeda Development Center Americas, Cambridge, Massachusetts, USA.; Gabriel A; Takeda Development Center Americas, Lexington, Massachusetts, USA.; Spalding W; Takeda Development Center Americas, Lexington, Massachusetts, USA.; Terreri B; Takeda Pharmaceuticals USA, Lexington, Massachusetts, USA.; Youssef A; Takeda Development Center Americas, Cambridge, Massachusetts, USA.; Kreidieh B; Jefferson Medical College, Thomas Jefferson University, Lankenau Hospital and Medical Research Center, Wynnewood, Pennsylvania, USA.; Kowey PR; Jefferson Medical College, Thomas Jefferson University, Lankenau Hospital and Medical Research Center, Wynnewood, Pennsylvania, USA.; Boules M; Takeda Pharmaceuticals USA, Lexington, Massachusetts, USA.

Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 0421030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1572-0241 (Electronic) Linking ISSN: 00029270 NLM ISO Abbreviation: Am J Gastroenterol Subsets: MEDLINE

Derakhchan K; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Lou Z; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Wang H; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Baughman R; Takeda Development Center Americas, Inc., Lexington, MA, USA.

Publisher: Bioexcel Publishing Ltd Country of Publication: England NLM ID: 101262187 Publication Model: eCollection Cited Medium: Print ISSN: 1745-1981 (Print) Linking ISSN: 17404398 NLM ISO Abbreviation: Drugs Context Subsets: PubMed not MEDLINE

Derakhchan, K; Chui, R W; Stevens, D; Gu, W; Vargas, H M

British Journal of Pharmacology. Jan 01, 2014 171(2):509-522

Iskenderian A; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Liu N; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Deng Q; Research, Shire Pharmaceuticals, Lexington, MA, 02421, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Huang Y; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Shen C; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Palmieri K; Research, Shire Pharmaceuticals, Lexington, MA, 02421, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Crooker R; Research, Shire Pharmaceuticals, Lexington, MA, 02421, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Lundberg D; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Kastrapeli N; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Pescatore B; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Romashko A; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Dumas J; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Comeau R; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Norton A; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Pan J; Discovery Therapeutics, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Rong H; Nonclinical Development, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Derakhchan K; Nonclinical Development, Shire Pharmaceuticals, Lexington, MA, USA.; Drug Discovery, Shire, Cambridge, MA, USA.; Ehmann DE; Research, Shire Pharmaceuticals, Lexington, MA, 02421, USA. dehmann0@shire.com.; Drug Discovery, Shire, Cambridge, MA, USA. dehmann0@shire.com.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101561193 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5040 (Electronic) Linking ISSN: 20445040 NLM ISO Abbreviation: Skelet Muscle Subsets: MEDLINE

Conlon K; Nonclinical Development, Shire, Basingstoke, United Kingdom (K.C., C.B.); Shire-Movetis, Turnhout, Belgium (J.H.D.M., J.A.J.S.); Biopta Ltd, Glasgow, United Kingdom (L.C.); Java Clinical Research, Dublin, Ireland (J.M.); and Nonclinical Development, Shire, Lexington, Massachusetts (K.D., P.R.W.).; De Maeyer JH; Nonclinical Development, Shire, Basingstoke, United Kingdom (K.C., C.B.); Shire-Movetis, Turnhout, Belgium (J.H.D.M., J.A.J.S.); Biopta Ltd, Glasgow, United Kingdom (L.C.); Java Clinical Research, Dublin, Ireland (J.M.); and Nonclinical Development, Shire, Lexington, Massachusetts (K.D., P.R.W.).; Bruce C; Nonclinical Development, Shire, Basingstoke, United Kingdom (K.C., C.B.); Shire-Movetis, Turnhout, Belgium (J.H.D.M., J.A.J.S.); Biopta Ltd, Glasgow, United Kingdom (L.C.); Java Clinical Research, Dublin, Ireland (J.M.); and Nonclinical Development, Shire, Lexington, Massachusetts (K.D., P.R.W.).; Schuurkes JAJ; Nonclinical Development, Shire, Basingstoke, United Kingdom (K.C., C.B.); Shire-Movetis, Turnhout, Belgium (J.H.D.M., J.A.J.S.); Biopta Ltd, Glasgow, United Kingdom (L.C.); Java Clinical Research, Dublin, Ireland (J.M.); and Nonclinical Development, Shire, Lexington, Massachusetts (K.D., P.R.W.).; Christie L; Nonclinical Development, Shire, Basingstoke, United Kingdom (K.C., C.B.); Shire-Movetis, Turnhout, Belgium (J.H.D.M., J.A.J.S.); Biopta Ltd, Glasgow, United Kingdom (L.C.); Java Clinical Research, Dublin, Ireland (J.M.); and Nonclinical Development, Shire, Lexington, Massachusetts (K.D., P.R.W.).; McRedmond J; Nonclinical Development, Shire, Basingstoke, United Kingdom (K.C., C.B.); Shire-Movetis, Turnhout, Belgium (J.H.D.M., J.A.J.S.); Biopta Ltd, Glasgow, United Kingdom (L.C.); Java Clinical Research, Dublin, Ireland (J.M.); and Nonclinical Development, Shire, Lexington, Massachusetts (K.D., P.R.W.).; Derakhchan K; Nonclinical Development, Shire, Basingstoke, United Kingdom (K.C., C.B.); Shire-Movetis, Turnhout, Belgium (J.H.D.M., J.A.J.S.); Biopta Ltd, Glasgow, United Kingdom (L.C.); Java Clinical Research, Dublin, Ireland (J.M.); and Nonclinical Development, Shire, Lexington, Massachusetts (K.D., P.R.W.).; Wade PR; Nonclinical Development, Shire, Basingstoke, United Kingdom (K.C., C.B.); Shire-Movetis, Turnhout, Belgium (J.H.D.M., J.A.J.S.); Biopta Ltd, Glasgow, United Kingdom (L.C.); Java Clinical Research, Dublin, Ireland (J.M.); and Nonclinical Development, Shire, Lexington, Massachusetts (K.D., P.R.W.) paulrwade@comcast.net.

Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE

Chou S; Division of Infectious Diseases, Oregon Health & Science University, USA; Portland Veterans Affairs Health Care System, OR USA. Electronic address: chous@ohsu.edu.; Ercolani RJ; Portland Veterans Affairs Health Care System, OR USA.; Derakhchan K; Global Nonclinical Development, Shire Pharmaceuticals, Cambridge, MA USA.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE

Deng, Q.; Palmieri, K.; Crooker, R.; Ehmann, D.E.; Iskenderian, A.; Liu, N.; Huang, Y.; Shen, C.; Lundberg, D.; Kastrapeli, N.; Pescatore, B.; Romashko, A.; Dumas, J.; Comeau, R.; Norton, A.; Pan, J.; Rong, H.; Derakhchan, K.

In: Skeletal Muscle. (Skeletal Muscle, 27 October 2018, 8(1))

Shinagawa, K; Derakhchan, K; Nattel, S

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY; MAR 2003, 26 3, p752-p764, 13p.